Age (years) |
|
Mean ± SD (n) |
64.5 ± 8.4 (105) |
Range (Min, Median, Max) |
(40, 64, 82) |
Sex, (%) n/N |
|
Male |
74.3% (78/105) |
Female |
25.7% (27/105) |
NYHA Class (%) n/N |
|
Class I |
5.7% (6/105) |
Class II |
57.1% (60/105) |
Class III |
37.1% (39/105) |
Class IV |
0.0% (0/105) |
Cardiomyopathy Etiology (%) n/N |
|
Non-ischemic |
58.1% (61/105) |
Ischemic |
41.9% (44/105) |
Prior Cardiac Interventions (%) n/N |
|
ICD Implant |
68.6% (72/105) |
Valve Replacement |
52.4% (55/105) |
CABG |
3.8% (4/105) |
PCI |
3.8% (4/105) |
Valve Repair |
1.0% (1/105) |
Comorbidities (%) n/N |
|
Hypertension |
68.6% (72/105) |
Hypercholesterolemia |
52.4% (55/105) |
Smoker |
49.5% (52/105) |
Diabetes Mellitus |
42.9% (45/105) |
Dilated Cardiomyopathy |
23.8% (25/105) |
Renal Disease |
10.5% (11/105) |
CVA |
9.5% (10/105) |
COPD |
9.5% (10/105) |
Neoplastic Disease |
5.7% (6/105) |
Alcoholic |
3.8% (4/105 |
Valvular Disease |
3.8% (4/105) |
Cardiac Medication (%) n/N |
|
Beta-Blockers |
83.8% (88/105) |
Diuretics |
71.4% (75/105) |
Aldosterone Antagonist |
58.1% (61/105) |
ACE |
56.2% (59/105) |
Antiplatelets |
43.8% (46/105) |
ARB |
36.2% (38/105) |
Anticoagulants |
23.8% (25/105) |